NC-LENOVO
28.2.2024 15:01:36 CET | Business Wire | Press release
Lenovo (HKSE: 992) (ADR: LNVGY) is rolling out a new solution to help customers extend the lifecycle of their devices with cost-efficient IT choices for a more sustainable future. Through Lenovo Certified Refurbished, organizations can deploy refurbished PCs that cater to their different computing needs and help manage their IT carbon footprint. Lenovo TruScale Device as a Service (DaaS) customers will also have more options to optimize their IT mix according to their unique economic and business needs, and with circularity in mind. Only Lenovo and accredited partners will offer the Lenovo certification, guaranteeing industry-leading quality devices that businesses can depend on.
“Environmental sustainability is a leading concern for businesses of every size, in every sector,” said Claudia Contreras, Executive Director of Global Sustainability Services for Lenovo. “Lenovo Certified Refurbished extends the lifecycle of our technology to improve ROI and help reduce waste, offering a solution that provides customers a purchase option to help support a more sustainable future. Certified Refurbished will help reduce e-waste, give devices new life, and positively contribute to the circular economy.”
Refurbishment, reuse, and recycling are key concepts in the circular economy, a resource and consumption system that helps mitigate waste. Lenovo is committed to implementing circular practices at every stage of the IT lifecycle, and as a leading global PC manufacturer, is uniquely qualified to help customers meet sustainability goals and embrace the benefits of circularity with confidence. Through the Lenovo 360 Circle community, channel partners are also aligned with collaborative actions to drive circular outcomes for customers and build a more sustainable future.
Lenovo’s 2023 Global Study of CIOs found that 60% of CIOs are turning towards as a Service (aaS) offerings for their tech stacks, including for sustainability management, and 62% said they find it challenging for their organization to reach sustainability goals. Outcome-based consumption models like Lenovo TruScale DaaS help businesses efficiently manage services, cost reduction, and waste reduction through a single source with the flexibility to scale as needed.
“Along with unified program management and streamlined financing, Lenovo TruScale DaaS offers lifecycle transformation approaches – including IT carbon footprint management and e-waste reduction – that help drive circularity and move customers closer to their sustainability goals while also helping to improve productivity and cost considerations. We’re excited to extend TruScale DaaS benefits to include options like Lenovo Certified Refurbished and help make IT circularity more achievable for customers,” said Anupam Garg, Lenovo Digital Workplace Solutions Offering Development leader.
Lenovo Certified Refurbished PCs undergo comprehensive data sanitization; expert testing to meet Lenovo’s high quality, security, and performance standards; and transparent, consistent quality grading. Access to Lenovo’s global support network provides added assurance that there is no compromise on security safeguards or PC performance, and that the refurbished devices will have a productive operational life with up to three years of standard warranty (with the option to upgrade). Lenovo Certified Refurbished PCs can help customers lower technology outlays while retaining a high level of performance and functionality, and refurbished devices may open a wider pool of options for budget-conscious organizations.
Lenovo Certified Refurbished PCs will be available initially in Denmark, France, Germany, and the U.K., with a planned global rollout. Lenovo Certified Refurbished is the latest in a series of Lenovo offerings that aid customers in their sustainability journeys. Learn more about Lenovo’s Sustainability Solutions.
About Lenovo
Lenovo is a US$62 billion revenue global technology powerhouse, ranked #217 in the Fortune Global 500, employing 77,000 people around the world, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company by further expanding into growth areas that fuel the advancement of ‘New IT’ technologies (client, edge, cloud, network, and intelligence) including server, storage, mobile, software, solutions, and services. This transformation together with Lenovo’s world-changing innovation is building a more inclusive, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992)(ADR: LNVGY). To find out more visit https://www.lenovo.com and read about the latest news via our StoryHub.
LENOVO and TRUSCALE are trademarks of Lenovo. ©2024 Lenovo. All rights reserved.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240228104727/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom